We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYZN
11551
CALL
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$201K ﹤0.01%
+384
New +$240K
CAMP
11552
CALL
DELISTED
CalAmp Corp.
CAMP
$201K ﹤0.01%
804
-1,600
-67% -$406K
PRTK
11553
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$201K ﹤0.01%
28,500
-5,900
-17% -$42.5K
RDBXW
11554
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
$201K ﹤0.01%
+365,500
New +$358K
FUSE.U
11555
DELISTED
Fusion Acquisition Corp. Units, each consisting of one share of Class A common stock, $0.0001 par va
FUSE.U
$201K ﹤0.01%
+19,189
New +$234K
BF.B icon
11556
PUT
Brown-Forman Class B
BF.B
$13B
$200K ﹤0.01%
+2,900
New +$212K
CPF icon
11557
PUT
Central Pacific Financial
CPF
$1.02B
$200K ﹤0.01%
+7,500
New +$171K
KW
11558
PUT
DELISTED
Kennedy-Wilson Holdings
KW
$200K ﹤0.01%
+9,900
New +$186K
NMCO icon
11559
Nuveen Municipal Credit Opportunities Fund
NMCO
$580M
$200K ﹤0.01%
+14,267
New +$198K
QMCO icon
11560
Quantum Corp
QMCO
$451M
$200K ﹤0.01%
1,201
+345
+40% +$54.9K
RDGT
11561
Ridgetech Inc
RDGT
$2.72M
$200K ﹤0.01%
+5
New +$208K
AIMC
11562
DELISTED
Altra Industrial Motion Corp
AIMC
$200K ﹤0.01%
3,623
-3,563
-50% -$207K
HCAP
11563
DELISTED
Harvest Capital Credit Corporation
HCAP
$200K ﹤0.01%
+23,168
New +$187K
CFRX
11564
DELISTED
ContraFect Corporation
CFRX
$200K ﹤0.01%
522
+184
+54% +$79.4K
FRMM
11565
PUT
Forum Markets
FRMM
$81.4M
$199K ﹤0.01%
+8
New +$143K
KRG icon
11566
PUT
Kite Realty
KRG
$5.37B
$199K ﹤0.01%
+10,300
New +$186K
LILAK icon
11567
CALL
Liberty Latin America Class C
LILAK
$1.71B
$199K ﹤0.01%
16,830
-27,390
-62% -$300K
ZSAN
11568
DELISTED
Zosano Pharma Corporation
ZSAN
$199K ﹤0.01%
+4,592
New +$192K
CKPT
11569
DELISTED
Checkpoint Therapeutics
CKPT
$198K ﹤0.01%
+6,294
New +$211K
CRVS icon
11570
Corvus Pharmaceuticals
CRVS
$1.16B
$198K ﹤0.01%
+64,271
New +$232K
ORMP icon
11571
Oramed Pharmaceuticals
ORMP
$178M
$198K ﹤0.01%
+19,435
New +$160K
VHAQ.WS
11572
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$198K ﹤0.01%
+521,794
New +$280K
KAIRW
11573
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$198K ﹤0.01%
+367,544
New +$304K
ARCO icon
11574
Arcos Dorados Holdings
ARCO
$1.77B
$197K ﹤0.01%
39,288
+7,949
+25% +$40.8K
NUVB.WS
11575
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$197K ﹤0.01%
+73,713
New +$213K

Similar funds

Citadel Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
  • Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Citadel Advisors opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.